The Endocannabinoid System – A Key to Women’s Health?

What is the Endocannabinoid System?

The Endocannabinoid System (ECS) is a complex network of natural compounds, receptors, and enzymes present in the human body. It influences various physiological processes, including pain regulation, brain development, appetite, reproduction, and gut motility.[1] This system is found in nearly all living organisms—except insects—highlighting its essential importance for vital body functions. The ECS is named after the discovery that certain compounds from the cannabis plant, known as phytocannabinoids, can have effects similar to those of endogenous cannabinoids produced by the body. The primary psychoactive component of cannabis, Δ9-tetrahydrocannabinol (THC), binds to the same receptors as these natural substances.

Although the ECS was discovered in the 1960s, many of its functions remain incompletely understood. Its gender-specific effects, in particular, have not been adequately explored.

Why is the ECS Relevant for Women’s Health?

It is well established that the ECS is closely linked to hormonal processes. Studies show that it plays a role in regulating the menstrual cycle, fertility, and menopause.[2][3] The potential for treating female-specific conditions such as endometriosis, premenstrual syndrome (PMS), or chronic pain is particularly intriguing. The ECS could be a key to new therapeutic approaches; however, there are currently few targeted clinical studies examining medical cannabis for these indications.

A better understanding of the ECS is not only scientifically desirable but also urgently needed. Women are often overlooked in medical research, and many of their ailments remain underdiagnosed or inadequately treated. Medical cannabis could offer an alternative or complementary option, especially for patients who do not respond sufficiently to conventional therapies. Furthermore, women tend to experience chronic pain more frequently, which is one of the most common applications of medical cannabis. Therefore, it is even more important to investigate pain perception and the response to pain medication from a gender-specific perspective.[4]

Why We Need More Gender-Specific Research

On the occasion of this year’s International Women’s Day, it is time to bring this topic into sharper focus. A better understanding of the ECS could not only help to apply medical cannabis more effectively but also open new doors for personalized medicine. A gender-specific approach in cannabis research is long overdue.

[1] Fowler, C. J. (2010). Anandamide uptake explained? Trends in Pharmacological Sciences, 33(4), 181–185.
[2] Santoro, A., Mele, E., Marino, M., Viggiano, A., Nori, S. L., & Meccariello, R. (2021). The complex interplay between the endocannabinoid system and the estrogen system in the central nervous system and periphery. International Journal of Molecular Sciences, 22(2), 972. https://doi.org/10.3390/ijms22020972
[3] Di Blasio, A. M., Vignali, M., & Gentilini, D. (2013). The endocannabinoid pathway and the female reproductive organs. Journal of Molecular Endocrinology, 50(1), R1-9. https://doi.org/10.1530/JME-12-0182
[4] Schmerzgesellschaft. (n.d.). Schmerz bei Frauen und Männern. Abgerufen von https://www.schmerzgesellschaft.de/patienteninformationen/besonderheiten-bei-schmerz/schmerz-bei-frauen-und-maenner

Anything else?

Do you have specific questions or suggestions for the Cannabis Briefing? Then send us an email to briefing@cansativa.de. If you are interested in revolutionising the cannabis industry with us, then stay tuned and follow our briefings!

We wish you a good read!

Best wishes from both of us,